tiprankstipranks
Verrica Pharmaceuticals CCO Joe Bonaccorso Resigns, Assumes Consulting Role
Company Announcements

Verrica Pharmaceuticals CCO Joe Bonaccorso Resigns, Assumes Consulting Role

Don't Miss our Black Friday Offers:

Verrica Pharmaceuticals (VRCA) has provided an announcement.

Joe Bonaccorso has announced his resignation as the Chief Commercial Officer of Verrica Pharmaceuticals Inc., effective August 30, 2024. As part of his separation, he is set to receive a year’s base salary and potentially 12 months of paid health coverage. Furthermore, he will enter a consulting role with the company until August 2025, during which he will not receive cash compensation but will continue to vest in stock options and awards.

For detailed information about VRCA stock, go to TipRanks’ Stock Analysis page.

Related Articles
TheFlyVerrica Pharmaceuticals 44.96M share Spot Secondary priced at $0.89
TheFlyVerrica Pharmaceuticals prices 44.96M shares at 89c in public offering
TheFlyVerrica Pharmaceuticals announces common stock offering, no amount given
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App